Names | |
---|---|
IUPAC name (4S)-N--4-(phenylsulfanyl)-L-proline | |
Systematic IUPAC name (2S,4S)-1--4-(phenylsulfanyl)pyrrolidine-2-carboxylic acid | |
Identifiers | |
CAS Number | |
3D model (JSmol) | |
ChEBI | |
ChEMBL | |
ChemSpider | |
DrugBank | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula | C15H19NO3S2 |
Molar mass | 325.44 g·mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). Infobox references |
This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources. Find sources: "Zofenoprilat" – news · newspapers · books · scholar · JSTOR (October 2022) |
Zofenoprilat is an angiotensin-converting enzyme inhibitor, and is the free sulfhydryl active metabolite of zofenopril.
References
- Subissi, A; Evangelista, S; Giachetti, A (1999). "Preclinical Profile of Zofenopril: An Angiotensin Converting Enzyme Inhibitor with Peculiar Cardioprotective Properties". Cardiovascular Drug Reviews. 17 (2): 115. doi:10.1111/j.1527-3466.1999.tb00008.x.
Angiotensin receptor modulators | |
---|---|
ATRTooltip Angiotensin receptor |
|
Combinations: |
This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |